José Rafael Almarales-Navarro

José Rafael Almarales-Navarro

Auto-generated profile, based on publicly available information

José Rafael Almarales-Navarro

Fundación Universitaria del Área Andina, Colombia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
GCGianmarco Camelo-Pardo
Gianmarco Camelo-Pardo
AMAlejandra Mendoza-Monsalve
Alejandra Mendoza-Monsalve
MLMaricel Licht
Maricel Licht
AOAngélica Lucero Ortiz-Córdoba
Angélica Lucero Ortiz-Córdoba
JAJosé Rafael Almarales-Navarro
José Rafael Almarales-Navarro
EMEdgar Fabián Manrique-Hernández
Edgar Fabián Manrique-Hernández
Objective: The aim of this study was to assess the cost-effectiveness of early versus late initiation of extracorporeal membrane oxygenation (ECMO) in pediatric patients with acute respiratory distress syndrome admitted to the intensive care unit. Methods: A cost-effectiveness analysis was conducted from the hospital provider perspective, comparing early (≤7 days) versus late (>7 days) initiation of ECMO. Direct medical costs and 90-day survival were incorporated into a decision tree to estimate the incremental cost-effectiveness ratio. Deterministic and probabilistic sensitivity analyses were performed using a willingness-to-pay threshold equivalent to three times the Colombian gross domestic product per capita. Results: Among 78 patients, most patients received early ECMO initiation, and this strategy was associated with similar mortality and comparable total direct medical costs compared with late initiation. Probabilistic simulations indicated a higher probability of cost-effectiveness for early initiation across different willingness-to-pay thresholds. Cost parameters were the main drivers of variability in the incremental cost-effectiveness ratio. Conclusions: No statistically significant differences were observed between early and late ECMO initiation in survival or costs. A possible economic trend favoring early initiation should be interpreted cautiously, given limited statistical power.